文献速递重症综合管理与镇静镇痛创伤与烧伤

手术创伤与失血对肿瘤生长和复发的影响

Operative Trauma and Blood Loss - Impact on Tumor Growth and Recurrence.
PubMed 文献 · Shock · 2021-01-01
一句话结论手术创伤和失血通过炎症与免疫抑制反应可能促进肿瘤增殖、转移和复发。

本文综述了癌症患者手术切除原发肿瘤过程中,手术创伤和失血对免疫系统的影响。术中失血导致血流减少、区域缺氧和微环境改变,引发以促炎细胞因子(如 TNF-α、IL-6)和急性期蛋白释放为特征的炎症反应,并伴随抗炎细胞因子(如转化生长因子-β)和前列腺素(如前列腺素 E2)升高,导致细胞免疫抑制。免疫抑制状态表现为巨噬细胞抗原提呈能力降低、淋巴细胞增殖和活化改变、Th1/Th2 平衡向 Th2 偏移及自然杀伤细胞活性下降,其严重程度与手术范围和持续时间相关。越来越多的证据提示,出血和手术创伤后的免疫抑制可能不仅是术后并发症的危险因素,还可能促进肿瘤增殖、转移生长和复发;控制围手术期炎症可能对肿瘤生长、转移形成和复发产生积极影响。

要点

  • 术中失血相关的大手术创伤导致区域缺氧和微环境改变,刺激促炎细胞因子(如 TNF-α、IL-6)释放。
  • 炎症状态伴随抗炎细胞因子(如转化生长因子-β)和前列腺素(如前列腺素 E2)升高,可导致细胞免疫抑制和全身免疫抑制。
  • 免疫抑制表现为巨噬细胞抗原提呈能力降低、淋巴细胞增殖和活化改变、Th1/Th2 平衡向 Th2 偏移及自然杀伤细胞活性下降。
  • 免疫抑制的严重程度与手术范围和持续时间相关。
  • 越来越多的证据提示,出血和手术创伤后的免疫抑制可能促进肿瘤增殖、转移生长和复发。

适用人群与场景

  • 癌症患者,接受原发肿瘤手术切除者。

研究设计与关键结果

  • 本文为综述,描述了失血和手术创伤导致免疫抑制的级联事件及机制,并阐述其对肿瘤生长和复发的影响。
  • 术中失血导致血流减少、区域缺氧、代谢和微环境改变,刺激促炎细胞因子(如 TNF-α、IL-6)和急性期蛋白释放。
  • 抗炎细胞因子(如转化生长因子-β)和前列腺素(如前列腺素 E2)升高可导致细胞免疫抑制和全身免疫抑制。
  • 免疫抑制表现为巨噬细胞抗原提呈能力降低、淋巴细胞增殖和活化改变、Th1/Th2 平衡向 Th2 偏移及自然杀伤细胞活性下降。
  • 免疫抑制的严重程度与手术范围和持续时间相关。
  • 越来越多的证据提示,出血和手术创伤后的免疫抑制可能促进肿瘤增殖、转移生长和复发。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尝试控制围手术期炎症以减少术后免疫抑制的不良影响,可能对肿瘤生长、转移形成和复发产生积极影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

In cancer patients, surgical removal of the primary tumor is one of the major steps within a multimodal therapy concept toward eliminating the disease and limiting further progression. In this respect, surgical trauma can have potent effects on the patient's immune system. Intraoperative blood loss associated with major surgical trauma leads to reduced blood flow, regional hypoxia, metabolic, and microenvironmental alterations stimulating an inflammatory response characterized by the release of pro-inflammatory cytokines (i.e., TNF-α, IL-6) and acute-phase proteins. The inflammatory state is accompanied by and intertwined with a counter-regulatory anti-inflammatory response reflected in the rise of anti-inflammatory cytokines (i.e., transforming growth factor-β) and prostaglandins (i.e., prostaglandin E2) which can lead to a depression of cell-mediated immunity and systemic immunosuppression. This results in a highly vulnerable state with concurrent expression of pro- and anti-inflammatory cytokines alternately predominating. The immunosuppressive state is characterized by a reduced antigen-presentation capacity of macrophages, alterations in lymphocyte proliferation, and activation as well as a shift of the Th1/Th2 (T helper cells 1 and 2) balance toward Th2 and a decrease in natural killer cell activity. The severity of the immunosuppression thereby correlates with the extent and the duration of the surgical procedure. Growing evidence suggests that the immunosuppressive state following hemorrhage and surgical trauma might not only be a risk factor for postoperative complications but also facilitate tumor proliferation, metastatic growth, and recurrence. This article provides an overview of the cascade of events and underlying mechanisms resulting in immunosuppression and describes the impact of hemorrhage and major surgical trauma on tumor growth and recurrence. Attempts to control for perioperative inflammation thereby reducing the adverse effects of postoperative immunosuppression could have positive effects on tumor growth, metastasis formation, and recurrence.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Pretzsch E, Bösch F, Renz B, et al. Operative Trauma and Blood Loss - Impact on Tumor Growth and Recurrence. Shock. 2021. PMID: 32881756. doi:10.1097/SHK.0000000000001656

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。